New York lawmakers won't pass a 340B drug program protection bill this session, disappointing hospitals and health centers ...

Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. Hospitals, which ...

Eli Lilly and Company said Monday evening that it will soon end 340B discount pricing for some of the hospitals that have not ...

Hospitals affiliated with Mount Sinai, the University of Michigan and the University of Kansas allege that CVS artificially ...

Three major hospital systems have accused CVS of allegedly diverting hundreds of millions from the federal 340B Drug Pricing Program.

This appeal concerns Maine's effort to use state law to impose additional obligations on drug manufacturers who participate ...

The 340B Drug Pricing Program is under pressure from multiple directions: pharmacy benefit manager litigation, drugmaker contract pharmacy restrictions, and a federal rebate pilot that courts have ...

Eli Lilly said last night it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation ...

When hospitals overcharge insurers for drugs they bought at deep 340B discounts, taxpayers, employers, and insured patients ...

In April, members of Congress questioned hospital CEOs about the rising cost of health care - and particularly criticized ...

Effective compliance now spans transaction eligibility, OPAIS synchronization, Medicaid exclusion validation, cost-report ...

A legal battle between the federal government and nearly half the states could affect healthcare for millions of people.